NAV
$54.16
AUM
$773.1M
Expense Ratio
-
Dividend Yield
1.41%
Beta
0.61
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +12.92% | +5.20% | +9.16% | +22.62% | +16.32% | +11.99% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 4.27% |
| 2 | HSBA.L | HSBC Holdings PLC | 2.19% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 2.02% |
| 4 | AZN.L | AstraZeneca PLC | 1.91% |
| 5 | NOVN.SW | Novartis AG Registered Shares | 1.88% |
| 6 | NESN.SW | Nestle SA | 1.78% |
| 7 | SHEL.L | Shell PLC | 1.60% |
| 8 | SIE.DE | Siemens AG | 1.59% |
| 9 | SAP.DE | SAP SE | 1.29% |
| 10 | SAN.MC | Banco Santander SA | 1.22% |
The fund, using a "passive" or indexing investment approach, seeks investment results that correspond generally to the performance, of the underlying index, which is designed to track the performance of the developed markets in Europe, while mitigating exposure to fluctuations between the value of the U.S. dollar and the currencies of the countries included in the underlying index. It will invest at least 80% of its total assets in component securities of the underlying index.
Inception Date: 2013-10-01